JANE STREET GROUP, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2023$407,915
-0.3%
146,732
-34.7%
0.00%
Q1 2023$409,056
+72.2%
224,756
+379.6%
0.00%
Q4 2022$237,581
+152.7%
46,860
+148.3%
0.00%
Q3 2022$94,000
-40.9%
18,874
-55.7%
0.00%
Q2 2022$159,000
-90.2%
42,605
-85.3%
0.00%
Q1 2022$1,630,000
+37.0%
290,306
+48.3%
0.00%
Q4 2021$1,190,000
-12.4%
195,803
+40.4%
0.00%
Q3 2021$1,359,000
-50.3%
139,458
-27.2%
0.00%
-100.0%
Q2 2021$2,734,000
-69.9%
191,448
-50.0%
0.00%
-80.0%
Q1 2021$9,085,000382,6760.01%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders